These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34375617)

  • 1. JAK inhibition in the type I interferonopathies.
    Crow YJ; Neven B; Frémond ML
    J Allergy Clin Immunol; 2021 Oct; 148(4):991-993. PubMed ID: 34375617
    [No Abstract]   [Full Text] [Related]  

  • 2. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
    Sanchez GAM; Reinhardt A; Ramsey S; Wittkowski H; Hashkes PJ; Berkun Y; Schalm S; Murias S; Dare JA; Brown D; Stone DL; Gao L; Klausmeier T; Foell D; de Jesus AA; Chapelle DC; Kim H; Dill S; Colbert RA; Failla L; Kost B; O'Brien M; Reynolds JC; Folio LR; Calvo KR; Paul SM; Weir N; Brofferio A; Soldatos A; Biancotto A; Cowen EW; Digiovanna JJ; Gadina M; Lipton AJ; Hadigan C; Holland SM; Fontana J; Alawad AS; Brown RJ; Rother KI; Heller T; Brooks KM; Kumar P; Brooks SR; Waldman M; Singh HK; Nickeleit V; Silk M; Prakash A; Janes JM; Ozen S; Wakim PG; Brogan PA; Macias WL; Goldbach-Mansky R
    J Clin Invest; 2018 Jul; 128(7):3041-3052. PubMed ID: 29649002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
    Kanazawa N; Ishii T; Takita Y; Nishikawa A; Nishikomori R
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):38. PubMed ID: 37087470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK inhibitors for the treatment of autoimmune and inflammatory diseases.
    Jamilloux Y; El Jammal T; Vuitton L; Gerfaud-Valentin M; Kerever S; Sève P
    Autoimmun Rev; 2019 Nov; 18(11):102390. PubMed ID: 31520803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
    Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
    J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Janus Kinase Family in Autoimmune Skin Diseases.
    Howell MD; Kuo FI; Smith PA
    Front Immunol; 2019; 10():2342. PubMed ID: 31649667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency.
    Alsohime F; Martin-Fernandez M; Temsah MH; Alabdulhafid M; Le Voyer T; Alghamdi M; Qiu X; Alotaibi N; Alkahtani A; Buta S; Jouanguy E; Al-Eyadhy A; Gruber C; Hasan GM; Bashiri FA; Halwani R; Hassan HH; Al-Muhsen S; Alkhamis N; Alsum Z; Casanova JL; Bustamante J; Bogunovic D; Alangari AA
    N Engl J Med; 2020 Jan; 382(3):256-265. PubMed ID: 31940699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
    Yu ZX; Song HM
    World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.
    Fragoulis GE; McInnes IB; Siebert S
    Rheumatology (Oxford); 2019 Feb; 58(Suppl 1):i43-i54. PubMed ID: 30806709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Treatment of Diseases of Immune Dysregulation.
    Mohan S
    Rheum Dis Clin North Am; 2023 Nov; 49(4):913-929. PubMed ID: 37821203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma.
    Zak M; Dengler HS; Rajapaksa NS
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126658. PubMed ID: 31522830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
    Günther C; Schmidt F; König N; Lee-Kirsch MA
    Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Switching to biological agents in autoimmune and autoinflammatory disorders: current targets and therapy.
    Gasparyan AY
    Curr Med Chem; 2015; 22(16):1890-1. PubMed ID: 25693591
    [No Abstract]   [Full Text] [Related]  

  • 14. JAK inhibitors in 2019, synthetic review in 10 points.
    Muller R
    Eur J Intern Med; 2019 Aug; 66():9-17. PubMed ID: 31178258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.
    Melki I; Frémond ML
    Curr Rheumatol Rep; 2020 Jun; 22(7):32. PubMed ID: 32548765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children.
    Du Y; Liu M; Nigrovic PA; Dedeoglu F; Lee PY
    J Allergy Clin Immunol; 2023 Mar; 151(3):607-618. PubMed ID: 36707349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [JAK inhibitors: Perspectives in internal medicine].
    El Jammal T; Gerfaud-Valentin M; Sève P; Jamilloux Y
    Rev Med Interne; 2019 Dec; 40(12):816-825. PubMed ID: 31699450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency.
    Hong Y; Capitani M; Murphy C; Pandey S; Cavounidis A; Takeshita H; Nanthapisal S; Yasuda T; Bader-Meunier B; McCreary D; Omoyinmi E; Rao A; Booth C; Gilmour K; Sebire N; Shah N; Klein N; Bullock AN; Eleftheriou D; Uhlig HH; Brogan P
    J Allergy Clin Immunol; 2020 Feb; 145(2):701-705.e8. PubMed ID: 31775019
    [No Abstract]   [Full Text] [Related]  

  • 19. JAK-STAT inhibitors for the treatment of immunomediated diseases.
    Serra López-Matencio JM; Morell Baladrón A; Castañeda S
    Med Clin (Barc); 2019 May; 152(9):353-360. PubMed ID: 30527218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review.
    Wen J; Hu H; Chen M; Yang H; Zhao Y; Liu Y
    J Immunol Res; 2021; 2021():2324400. PubMed ID: 34966823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.